Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Share
Climate and Energy
Colbeck’s Corner wind farm in Carson County, Texas, provides more than 60% of Johnson & Johnson’s electricity use in the U.S.
s a healthcare company, Johnson & Johnson understands that climate health can affect human health. In fact, we’re seeing climate change impact health in new ways by changing infectious disease patterns and increasing the risk of drought and food insecurity. We have taken sustained, long-term action to address our greenhouse gas (GHG) emissions and we are encouraging our supply chain to do the same. We also support responsible climate and energy policy around the world.
Our Approach
For many years, we’ve participated in coalitions that publicly support actions to promote a low carbon economy and mitigate climate change, such as the World Wildlife Fund's Climate Savers Program, The Climate Group's RE100 program and the United Nations Framework Convention on Climate Change. We believe industry has an important role to play in responding to climate change by implementing voluntary reductions of GHGs within their control. As such, we have a long history of commitments and action to improve the energy efficiency of our facilities and source cleaner energy to power our operations.
Our Commitment to Energy Leadership
Highlights from Johnson & Johnson's 30 years of energy innovation and leadership.
Energy Management
Johnson & Johnson establishes its formal energy management program.
Commitment to Reduce CO2 Emissions
Johnson & Johnson establishes its first enterprise-wide public commitment to reducing CO2 emissions.
Solar Energy
Johnson & Johnson builds its first on-site solar array. Since then we have completed 48 additional solar projects, equating to 22 megawatts, now installed on our properties globally.
CO2 Capital Relief Program
Johnson & Johnson establishes a CO2 capital relief program, which today saves about 276,196 metric tons of CO2 annually.
CO2 2020 Reduction Goals
Johnson & Johnson announces its goal to reduce CO2 emissions by 20% by 2020 and increase on-site clean energy capacity to 50 megawatts by 2015.
Wind Turbines
Johnson & Johnson builds two 3-megawatt wind turbines on its Medical Devices and Pharmaceutical manufacturing properties in Cork, Ireland; since then, we have added two more turbines, equating to 12 megawatts in total.
The American Business Act on Climate Pledge
Signed the White House American Business Act on Climate Pledge to demonstrate support for a global climate agreement. Committed to the RE100 program, a consortium of companies seeking to obtain 100% of their electricity from renewable sources.
Power Purchase Agreement
Johnson & Johnson executes a long-term power purchase agreement in the U.S. for a new 100-megawatt wind farm that will equate to around 60% of our electricity consumption in the U.S.
1986
2000
2001
2005
2010
2014
2015
2016
We Are Taking Steps to Help Create Even Greater Impact
We are partnering with organizations like C40 Cities Climate Leadership Group—a network of the world's 90 megacities that are committed to climate leadership and action—to help fund programs that will link climate action with the benefits to air quality and human health.
We are a founding member of the Climate Leadership Council, a coalition of industry, NGO and thought leaders seeking to address climate issues through a carbon dividends framework.
Our Goals
We have set a science-based scope 1 and 2 goal to reduce our absolute carbon emissions 20% by 2020, and 80% by 2050 compared to our 2010 baseline; and to produce or procure 35% of electricity use from renewable sources by 2020, and 100% by 2050. To see how we are progressing against our goals, please visit the latest Health for Humanity report.
Additional Resources
More From Johnson & Johnson
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.
